PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Paul T. Heath

Vaccination and herd immunity

what more do we know?

  • Harunor Rashid
  • Gulam Khandaker
  • Robert Booy
Current Opinion in Infectious Diseases 25(3):p 243-249, June 2012. | DOI: 10.1097/QCO.0b013e328352f727

Purpose of review

This review summarizes herd immunity, focusing on conceptual developments with application to vaccination programs.

Recent findings

The conventional idea of herd immunity is based on the relationship between the transmission dynamics of infectious agents and population immunity. However, there have been some recent conceptual developments in vaccine ‘herd immunity’ or ‘herd protection’ that address the complexities of imperfect immunity, heterogeneous populations, nonrandom vaccine uptake and ‘freeloaders’. Some vaccines may provide better protection than others; for instance, meningococcal conjugate vaccines are superior to polysaccharide vaccines, as is true of pneumococcal and Haemophilus influenzae type b vaccines. Achieving a very high uptake rate should be the target for certain vaccines, for example, measles vaccine, in order to prevent the disease effectively. Emerging issues, for example, waning of immunity after pertussis vaccination, are fresh challenges.

Summary

Herd immunity is a complex issue inherent to a vaccine and the population receiving the vaccine. We have more to learn and apply.

Copyright © 2012 Lippincott Williams & Wilkins, Inc.

Related Articles

Readers Of this Article Also Read

Most Popular